Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1690)
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
8,500
Price
$5.24
Total Value
$44.50K
Shares Held After
3,620,995
% of Holdings
0.2%
CENTENE CORP (CNC)
Burdick Kenneth A — Director
Shares
80,000
Price
$64.55
Total Value
$5.16M
Shares Held After
197,086
% of Holdings
28.9%
BECTON DICKINSON & CO (BDX)
Garrison Michael David — EVP & Pres Med.Essntl&BioPharm
Shares
1,100
Price
$151.48
Total Value
$166.63K
Shares Held After
14,272
% of Holdings
7.2%
Lyell Immunopharma, Inc. (LYEL)
Shook David — Chief Medical Officer
Shares
1,977
Price
$12.64
Total Value
$24.99K
Shares Held After
20,923
% of Holdings
8.6%
FRACTYL HEALTH, INC. (GUTS)
Rajagopalan Harith — Director
Shares
25,000
Price
$0.73
Total Value
$18.25K
Shares Held After
540,557
% of Holdings
4.6%
Sight Sciences, Inc. (SGHT)
Encrantz Staffan — Director
Shares
14,100
Price
$4.88
Total Value
$68.79K
Shares Held After
1,434,283
% of Holdings
1.0%
FRACTYL HEALTH, INC. (GUTS)
Sheffield Ian — Director
Shares
35,000
Price
$0.73
Total Value
$25.53K
Shares Held After
35,000
% of Holdings
100.0%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
29,430
Price
$4.02
Total Value
$118.43K
Shares Held After
7,353,263
% of Holdings
0.4%
FRACTYL HEALTH, INC. (GUTS)
BRADLEY WILLIAM — Director
Shares
68,493
Price
$0.73
Total Value
$50.33K
Shares Held After
84,622
% of Holdings
80.9%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Kung Winston — Director
Shares
2,026
Price
$7.91
Total Value
$16.03K
Shares Held After
12,140
% of Holdings
14.3%
ELI LILLY & Co (LLY)
Yuffa Ilya — EVP&Pres, LLY USA&Global Capab
Shares
2,500
Price
$1,150.77
Total Value
$2.88M
Shares Held After
29,804
% of Holdings
7.7%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Jenkins John Kenneth — Director
Shares
4,800
Price
$7.91
Total Value
$37.99K
Shares Held After
3,833
% of Holdings
55.6%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Altmeyer Anne — Director
Shares
2,412
Price
$7.91
Total Value
$19.09K
Shares Held After
7,579
% of Holdings
24.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$557.03
Total Value
$44.56K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
285
Price
$555.29
Total Value
$158.26K
Shares Held After
40,593
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
933
Price
$554.56
Total Value
$517.41K
Shares Held After
40,878
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
587
Price
$553.64
Total Value
$324.99K
Shares Held After
41,811
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
90
Price
$551.60
Total Value
$49.64K
Shares Held After
42,398
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
156
Price
$550.59
Total Value
$85.89K
Shares Held After
42,488
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
508
Price
$549.70
Total Value
$279.25K
Shares Held After
42,644
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
246
Price
$548.63
Total Value
$134.96K
Shares Held After
43,152
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
385
Price
$547.09
Total Value
$210.63K
Shares Held After
43,398
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$546.14
Total Value
$117.42K
Shares Held After
43,783
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
914
Price
$545.10
Total Value
$498.22K
Shares Held After
43,998
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
867
Price
$544.33
Total Value
$471.93K
Shares Held After
44,912
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$543.26
Total Value
$447.65K
Shares Held After
45,779
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,158
Price
$542.23
Total Value
$627.90K
Shares Held After
46,603
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
852
Price
$541.16
Total Value
$461.07K
Shares Held After
47,761
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$540.14
Total Value
$432.11K
Shares Held After
48,613
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$539.12
Total Value
$323.47K
Shares Held After
49,413
% of Holdings
1.2%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
6,418
Price
$6.21
Total Value
$39.86K
Shares Held After
700,000
% of Holdings
0.9%
Ridgetech Inc. (RDGT)
HRT FINANCIAL LP — 10% Owner
Shares
14,312
Price
$1.62
Total Value
$23.14K
Shares Held After
114,995
% of Holdings
12.4%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
725,330
Price
$0.02
Total Value
$13.78K
Shares Held After
1,040,004
% of Holdings
69.7%
111, Inc. (YI)
Sun Jian David — Director
Shares
115,440
Price
$0.22
Total Value
$25.40K
Shares Held After
583,111
% of Holdings
16.5%
Axsome Therapeutics, Inc. (AXSM)
Mahony Susan — Director
Shares
300
Price
$246.18
Total Value
$73.85K
Shares Held After
829
% of Holdings
26.6%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
643
Price
$249.00
Total Value
$160.11K
Shares Held After
30,389
% of Holdings
2.1%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,500
Price
$4.21
Total Value
$14.73K
Shares Held After
150,839
% of Holdings
2.3%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP & Chief Mfg and Supply Cha
Shares
23
Price
$424.14
Total Value
$9.76K
Shares Held After
1,454
% of Holdings
1.6%
INTUITIVE SURGICAL INC (ISRG)
LOEB GARY — EVP & Chief Legal and Complian
Shares
400
Price
$424.14
Total Value
$169.66K
Shares Held After
5,720
% of Holdings
6.5%
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
ORESHACK KURT — General Counsel
Shares
25,000
Price
$5.10
Total Value
$127.50K
Shares Held After
335,767
% of Holdings
6.9%
111, Inc. (YI)
Sun Jian David — Director
Shares
12,000
Price
$0.23
Total Value
$2.76K
Shares Held After
698,551
% of Holdings
1.7%
111, Inc. (YI)
Sun Jian David — Director
Shares
12,000
Price
$0.23
Total Value
$2.76K
Shares Held After
698,551
% of Holdings
1.7%
CERUS CORP (CERS)
BJERKHOLT ERIC — Director
Shares
20,454
Price
$2.60
Total Value
$53.18K
Shares Held After
261,679
% of Holdings
7.2%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
24,565
Price
$0.37
Total Value
$9.09K
Shares Held After
381,717
% of Holdings
6.0%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
345,235
Price
$0.37
Total Value
$127.74K
Shares Held After
5,364,623
% of Holdings
6.0%
Nuvation Bio Inc. (NUVB)
Mashal Robert — Director
Shares
25,000
Price
$4.73
Total Value
$118.25K
Shares Held After
225,000
% of Holdings
11.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
479,039
Price
$6.91
Total Value
$3.31M
Shares Held After
15,683,034
% of Holdings
3.1%
NEOGENOMICS INC (NEO)
TETRAULT LYNN A. — Director
Shares
5,307
Price
$11.29
Total Value
$59.92K
Shares Held After
91,422
% of Holdings
5.5%
Shattuck Labs, Inc. (STTK)
SIEGALL CLAY B — Director
Shares
62,500
Price
$4.00
Total Value
$250.00K
Shares Held After
318,608
% of Holdings
19.6%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
20,000
Price
$122.81
Total Value
$2.46M
Shares Held After
58,117
% of Holdings
25.6%
Showing 301–350 of 1690 transactions (page 7 of 34)